The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.